NCT02562300View on ClinicalTrials.gov

Uterotonics Using to Reduce Bleeding at Cesarean Section

PHASE2CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

April 30, 2015

Conditions

Postpartum Haemorrhage

Interventions

DRUG

Misoprostol

400 micrograms of sublingual misoprostol were given immediately after delivery of the neonate.

DRUG

Oxytocin

20 IU oxytocin dissolved in 1 L of Lactated Ringer's or glucose solution) at the rate of 125 ml /h were given immediately after delivery of the neonate.

All Listed Sponsors

lead

Assiut University

OTHER

NCT02562300 - Uterotonics Using to Reduce Bleeding at Cesarean Section | Biotech Hunter | Biotech Hunter